{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:22:28Z","timestamp":1768519348206,"version":"3.49.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biomedical Informatics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jbi.2024.104723","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:52:01Z","timestamp":1726595521000},"page":"104723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Proxy endpoints \u2014 bridging clinical trials and real world data"],"prefix":"10.1016","volume":"158","author":[{"given":"Maxim","family":"Kryukov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen P.","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macarena","family":"Villamea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9334-6331","authenticated-orcid":false,"given":"Ingrid","family":"O\u2019Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohn","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Dormont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziv","family":"Bar-Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-7496","authenticated-orcid":false,"given":"Brandon","family":"Rufino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jbi.2024.104723_b1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials \u2013 the gold standard for effectiveness research","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG: Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.jbi.2024.104723_b2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/JMDH.S160029","article-title":"Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making","volume":"11","author":"Katkade","year":"2018","journal-title":"J. Multidiscip. Healthc."},{"issue":"3","key":"10.1016\/j.jbi.2024.104723_b3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2020.07.2432","article-title":"The impact of missing\/incomplete data in real-world data studies","volume":"108","author":"Yang","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b4","doi-asserted-by":"crossref","first-page":"23539","DOI":"10.1038\/s41598-021-02950-4","article-title":"A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world","volume":"11","author":"Jang","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jbi.2024.104723_b5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/jdv.16180","article-title":"Real-world evidence of secukinumab in psoriasis treatment \u2013 a meta-analysis of 43 studies","volume":"34","author":"Augustin","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41531-024-00667-5","article-title":"Disease progression strikingly differs in research and real-world Parkinson\u2019s populations","volume":"10","author":"Beaulieu-Jones","year":"2024","journal-title":"Npj Parkinson\u2019s Dis."},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7326\/M22-1510","article-title":"Assessing heterogeneity of treatment effect in real-world data.","volume":"176","author":"Segal","year":"2023","journal-title":"Ann. Internal Med."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103422","article-title":"Drug repurposing using real-world data","volume":"28","author":"Tan","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41746-021-00452-1","article-title":"Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of alzheimer\u2019s disease","volume":"4","author":"Chen","year":"2021","journal-title":"Npj Digit. Med."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12874-019-0681-4","article-title":"Machine learning in medicine: a practical introduction","volume":"19","author":"Sidey-Gibbons","year":"2019","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"10.1016\/j.jbi.2024.104723_b11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.eij.2018.03.002","article-title":"Feature selection and classification systems for chronic disease prediction: A review","volume":"19","author":"Jain","year":"2018","journal-title":"Egypt. Inform. J."},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1109\/72.298224","article-title":"Using mutual information for selecting features in supervised neural net learning","volume":"5","author":"Battiti","year":"1994","journal-title":"IEEE Trans. Neural Netw."},{"issue":"1\u20133","key":"10.1016\/j.jbi.2024.104723_b13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/A:1012487302797","article-title":"Gene selection for cancer classification using support vector machines","volume":"46","author":"Guyon","year":"2002","journal-title":"Mach. Learn."},{"key":"10.1016\/j.jbi.2024.104723_b14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2021.103763","article-title":"A random forest method with feature selection for developing medical prediction models with clustered and longitudinal data","volume":"117","author":"Speiser","year":"2021","journal-title":"J. Biomed. Inform."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41746-021-00445-0","article-title":"A hierarchical expert-guided machine learning framework for clinical decision support systems: an application to traumatic brain injury prognostication","volume":"4","author":"Farzaneh","year":"2021","journal-title":"Npj Digit. Med."},{"key":"10.1016\/j.jbi.2024.104723_b16","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00496","article-title":"WERFE: A gene selection algorithm based on recursive feature elimination and ensemble strategy","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.jbi.2024.104723_b17","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1253\/circj.CJ-11-1236","article-title":"A risk score for predicting the incidence of type 2 diabetes in a middle-aged Korean cohort","volume":"76","author":"Lim","year":"2012","journal-title":"Circ. J."},{"issue":"9","key":"10.1016\/j.jbi.2024.104723_b18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0107584","article-title":"Non\u2013laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: Development, validation and comparison with other scores","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-019-0863-0","article-title":"Clinical risk prediction with random forests for survival, longitudinal, and multivariate (RF-SLAM) data analysis","volume":"20","author":"Wongvibulsin","year":"2019","journal-title":"BMC Med. Res. Methodol."},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/gerona\/glaa138","article-title":"Machine learning in aging: An example of developing prediction models for serious fall injury in older adults","volume":"76","author":"Speiser","year":"2020","journal-title":"J. Gerontol.: Ser. A"},{"issue":"10","key":"10.1016\/j.jbi.2024.104723_b21","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211053232","article-title":"Decision tree analysis for evaluating disease activity in patients with rheumatoid arthritis","volume":"49","author":"Wang","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b22","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1038\/s41598-021-87171-5","article-title":"Development of machine learning model for diagnostic disease prediction based on laboratory tests","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jbi.2024.104723_b23","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1373\/clinchem.2017.280768","article-title":"Deep learning makes its way to the clinical laboratory","volume":"63","author":"Jackups","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jbi.2024.104723_b24","series-title":"Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","first-page":"1721","article-title":"Intelligible models for HealthCare: Predicting pneumonia risk and hospital 30-day readmission","author":"Caruana","year":"2015"},{"key":"10.1016\/j.jbi.2024.104723_b25","series-title":"Chapman & Hall\/CRC Monographs on Statistics and Applied Probability","article-title":"Generalized Additive Models","author":"Hastie","year":"1990"},{"key":"10.1016\/j.jbi.2024.104723_b26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/096228029500400302","article-title":"Generalized additive models for medical research","volume":"4","author":"Hastie","year":"1995","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.jbi.2024.104723_b27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/biostatistics\/kxi028","article-title":"Lung cancer rate predictions using generalized additive models","volume":"6","author":"Clements","year":"2005","journal-title":"Biostatistics"},{"key":"10.1016\/j.jbi.2024.104723_b28","series-title":"Accurate Intelligible Models with Pairwise Interactions","author":"Lou","year":"2013"},{"issue":"2","key":"10.1016\/j.jbi.2024.104723_b29","first-page":"174","article-title":"Chronic inflammatory diseases and cardiovascular risk: a systematic review","volume":"27","author":"Roifman","year":"2011","journal-title":"Can. J. Cardiol."},{"issue":"11","key":"10.1016\/j.jbi.2024.104723_b30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","article-title":"Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.","volume":"49","author":"van der Heijde","year":"1990","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis","volume":"10","author":"Hanifin","year":"2001","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jbi.2024.104723_b32","series-title":"A dose-range finding study for ALX-0061 combination therapy in subjects with rheumatoid arthritis","year":"2024"},{"key":"10.1016\/j.jbi.2024.104723_b33","series-title":"A phase IIb study for ALX-0061 monotherapy in subjects with rheumatoid arthritis","year":"2024"},{"key":"10.1016\/j.jbi.2024.104723_b34","series-title":"Evaluation of upadacitinib in adolescent and adult patients with moderate to severe atopic dermatitis (eczema) (measure up 1)","year":"2024"},{"key":"10.1016\/j.jbi.2024.104723_b35","series-title":"A study to evaluate upadacitinib in combination with topical corticosteroids in adolescent and adult participants with moderate to severe atopic dermatitis (AD up)","year":"2024"},{"key":"10.1016\/j.jbi.2024.104723_b36","series-title":"Datacelerate)","year":"2024"},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1145\/507533.507538","article-title":"A preprocessing scheme for high-cardinality categorical attributes in classification and prediction problems","volume":"3","author":"Micci-Barreca","year":"2001","journal-title":"SIGKDD Explor. Newsl."},{"key":"10.1016\/j.jbi.2024.104723_b38","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.jbi.2024.104723_b39","unstructured":"O. de-identified Market Clarity Data (2007-2022), 2022."},{"issue":"2","key":"10.1016\/j.jbi.2024.104723_b40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087357","article-title":"Mutual information between discrete and continuous data sets","volume":"9","author":"Ross","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbi.2024.104723_b41","series-title":"InterpretML: A unified framework for machine learning interpretability","author":"Nori","year":"2019"},{"key":"10.1016\/j.jbi.2024.104723_b42","series-title":"Constrained generalized additive 2 model with consideration of high-order interactions","author":"Watanabe","year":"2021"},{"issue":"3","key":"10.1016\/j.jbi.2024.104723_b43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","article-title":"IgE, mast cells, and eosinophils in atopic dermatitis","volume":"41","author":"Liu","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jbi.2024.104723_b44","series-title":"CRC Standard Probability and Statistics Tables and Formulae, Student Edition","author":"Kokoska","year":"2000"},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/A:1012487302797","article-title":"Gene selection for cancer classification using support vector machines","volume":"46","author":"Guyon","year":"2002","journal-title":"Mach. Learn."},{"key":"10.1016\/j.jbi.2024.104723_b47","series-title":"Pattern Recognition in Practice IV","first-page":"403","article-title":"Comparative study of techniques for large-scale feature selection* *This work was suported by a SERC grant GR\/E 97549. The first author was also supported by a FPI grant from the Spanish MEC, PF92 73546684","volume":"vol. 16","author":"Ferri","year":"1994"},{"issue":"24","key":"10.1016\/j.jbi.2024.104723_b48","article-title":"MLxtend: Providing machine learning and data science utilities and extensions to Python\u2019s scientific computing stack","volume":"3","author":"Raschka","year":"2018","journal-title":"J. Open Sour. Softw."},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1109\/MSP.2004.1311138","article-title":"Model-order selection: a review of information criterion rules","volume":"21","author":"Stoica","year":"2004","journal-title":"IEEE Signal Process. Mag."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b50","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1038\/s41598-022-13616-0","article-title":"Development and validation of a prognostic prediction model including the minor lymphatic pathway for distant metastases in cervical cancer patients","volume":"12","author":"Thephamongkhol","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jbi.2024.104723_b51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection - A review and recommendations for the practicing statistician.","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom. J. Biometrisch. Zeitschrift"},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.patcog.2009.06.009","article-title":"Feature subset selection in large dimensionality domains","volume":"43","author":"Gheyas","year":"2010","journal-title":"Pattern Recognit."},{"issue":"20","key":"10.1016\/j.jbi.2024.104723_b53","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182010670","article-title":"Evaluation of feature selection techniques for breast cancer risk prediction.","volume":"18","author":"L\u00f3pez","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12920-021-00957-4","article-title":"Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods","volume":"14","author":"Zhang","year":"2021","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.jbi.2024.104723_b55","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105147","article-title":"Identification of hemodynamic biomarkers for bicuspid aortic valve induced aortic dilation using machine learning.","volume":"141","author":"Franco","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jbi.2024.104723_b56","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1010361","article-title":"Machine learning-based characterization of cuprotosis-related biomarkers and immune infiltration in Parkinson\u2019s disease.","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.jbi.2024.104723_b57","article-title":"Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods","volume":"10","author":"Platt","year":"2000","journal-title":"Adv. Large Margin Classif."},{"issue":"14","key":"10.1016\/j.jbi.2024.104723_b58","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1001\/jama.285.14.1865","article-title":"Predictors of cardiac events after major vascular SurgeryRole of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy","volume":"285","author":"Boersma","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jbi.2024.104723_b59","series-title":"Statistical Models: Theory and Practice","author":"Freedman","year":"2009"},{"issue":"5","key":"10.1016\/j.jbi.2024.104723_b60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: A gradient boosting machine.","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann. Statist."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"10.1016\/j.jbi.2024.104723_b62","series-title":"Surgery in Rheumatic and Musculoskeletal Disease","first-page":"97","article-title":"Chapter 5 - monitoring of disease and treatment of patients with rheumatic disease","volume":"vol. 15","author":"Gossec","year":"2018"},{"issue":"6","key":"10.1016\/j.jbi.2024.104723_b63","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23214","article-title":"Clinical relevance of eosinophils, basophils, serum total IgE level, allergen-specific IgE, and clinical features in atopic dermatitis","volume":"34","author":"Hu","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jbi.2024.104723_b64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdin.2020.10.002","article-title":"The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the global burden of disease study 2017.","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int."},{"issue":"6","key":"10.1016\/j.jbi.2024.104723_b65","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jdv.18841","article-title":"The association between atopic eczema and lymphopenia: Results from a UK cohort study with replication in US survey data","volume":"37","author":"Hollestein","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043310","article-title":"The interplay of type 1, type 2, and type 3 lymphocytes and cytokines in atopic dermatitis.","volume":"24","author":"Yamanaka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jbi.2024.104723_b67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molmed.2019.04.001","article-title":"Epidermal lipids: Key mediators of atopic dermatitis pathogenesis","volume":"25","author":"Bhattacharya","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b68","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.rdc.2009.10.007","article-title":"Laboratory tests to assess patients with rheumatoid arthritis: Advantages and limitations","volume":"35","author":"Pincus","year":"2009","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"6","key":"10.1016\/j.jbi.2024.104723_b69","first-page":"317","article-title":"Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine","volume":"115","author":"Bray","year":"2016","journal-title":"WMJ"},{"issue":"10","key":"10.1016\/j.jbi.2024.104723_b70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3928\/00904481-20140924-10","article-title":"Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice","volume":"43","author":"Litao","year":"2014","journal-title":"Pediatr. Ann."},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.berh.2019.01.006","article-title":"MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis.","volume":"32","author":"Lerner","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b72","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3734","article-title":"Baseline serum MMP-3 levels in patients with rheumatoid arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up.","volume":"14","author":"Houseman","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.jbi.2024.104723_b73","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","article-title":"Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm","volume":"9","author":"Robertson","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.jbi.2024.104723_b74","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061240","article-title":"Low-density lipoprotein cholesterol and the risk of rheumatoid arthritis: A prospective study in a Chinese cohort","volume":"14","author":"VanEvery","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.jbi.2024.104723_b75","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/rheumatology\/ker011","article-title":"Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis.","volume":"50","author":"Rooney","year":"2011","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jbi.2024.104723_b76","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.2147\/JIR.S335671","article-title":"Albumin\/globulin ratio as yin-yang in rheumatoid arthritis and its correlation to inflamm-aging cytokines.","volume":"14","author":"Chen","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jbi.2024.104723_b77","series-title":"Advances in Neural Information Processing Systems 30","first-page":"4765","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017"},{"issue":"9","key":"10.1016\/j.jbi.2024.104723_b78","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/014107680409700903","article-title":"Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know","volume":"97","author":"Suresh","year":"2004","journal-title":"J. R. Soc. Med."},{"issue":"2","key":"10.1016\/j.jbi.2024.104723_b79","first-page":"144","article-title":"Biomarkers in rheumatoid arthritis, what is new?","volume":"9","author":"Gavril\u0103","year":"2016","journal-title":"J. Med. Life"},{"issue":"4","key":"10.1016\/j.jbi.2024.104723_b80","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.berh.2011.10.007","article-title":"Assessment of control of rheumatoid arthritis disease activity","volume":"25","author":"Salomon-Escoto","year":"2011","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b81","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1067\/mjd.2001.117022","article-title":"A role for eosinophils in atopic dermatitis","volume":"45","author":"Leiferman","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.jbi.2024.104723_b82","doi-asserted-by":"crossref","DOI":"10.1097\/ACI.0000000000000198","article-title":"Biomarkers for atopic dermatitis: a systematic review and meta-analysis","volume":"15","author":"Thijs","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jbi.2024.104723_b83","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jaci.2017.06.046","article-title":"EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.","volume":"140","author":"Thijs","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jbi.2024.104723_b84","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s43441-022-00413-0","article-title":"Real-world data as external controls: Practical experience from notable marketing applications of new therapies.","volume":"56","author":"Izem","year":"2022","journal-title":"Ther. Innov. Regul. Sci."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b85","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41467-022-30908-1","article-title":"Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of pralsetinib in non-small cell lung cancer","volume":"13","author":"Popat","year":"2022","journal-title":"Nature Commun."},{"issue":"7855","key":"10.1016\/j.jbi.2024.104723_b86","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41586-021-03430-5","article-title":"Evaluating eligibility criteria of oncology trials using real-world data and AI","volume":"592","author":"Liu","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b87","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-022-01768-6","article-title":"Real-world data: a brief review of the methods, applications, challenges and opportunities","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s42256-020-00276-w","article-title":"A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data.","volume":"3","author":"Liu","year":"2021","journal-title":"Nat. Mach. Intell."},{"issue":"1","key":"10.1016\/j.jbi.2024.104723_b89","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1038\/s41467-023-43929-1","article-title":"High-throughput target trial emulation for Alzheimer\u2019s disease drug repurposing with real-world data","volume":"14","author":"Zang","year":"2023","journal-title":"Nature Commun."},{"key":"10.1016\/j.jbi.2024.104723_b90","series-title":"Semi-Supervised Learning for Electronic Phenotyping in Support of Precision Medicine","author":"Halpern","year":"2016"}],"container-title":["Journal of Biomedical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046424001412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046424001412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:13:25Z","timestamp":1759425205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1532046424001412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":90,"alternative-id":["S1532046424001412"],"URL":"https:\/\/doi.org\/10.1016\/j.jbi.2024.104723","relation":{},"ISSN":["1532-0464"],"issn-type":[{"value":"1532-0464","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proxy endpoints \u2014 bridging clinical trials and real world data","name":"articletitle","label":"Article Title"},{"value":"Journal of Biomedical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbi.2024.104723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104723"}}